Zhang Helen H - OmicsDI

Show results for

Unknown (180)
Transcriptomics (5)
Genomics (3)
Proteomics (3)
Metabolomics (2)

Organisms

Homo sapiens (7)
Mus musculus (2)
Porphyromonas gingivalis ATCC 33277 (1)
Enterococcus faecium (1)
Escherichia coli (1)

Repository

biostudies-arrayexpress (5)
EGA (3)
MetaboLights (2)
pride (2)
PanoramaPublic (1)

Tissue

Blood (1)
Cell culture (1)
T cell (1)

Technology Type

Mass Spectrometry (2)
Affymetrix 6.0 (1)
Illumina 1.2M, Affymetrix 6.0 (1)
Mass spectrometry (1)
NMR spectroscopy (1)
Affinity proteomics (1)
Bottom-up proteomics (1)
Data-dependent acquisition (1)
Shotgun proteomics (1)

Instrument Platform

Illumina NovaSeq 6000 (1)
Q Exactive (1)
Varian INOVA (1)

Publication Date

2024 (2)
2022 (1)
2016 (1)
2015 (1)
2014 (1)
2013 (1)
2018 (1)
2021 (1)

CHEBI ID

CHEBI:111517 (1)
CHEBI:116314 (1)
CHEBI:11805 (1)
CHEBI:12937 (1)
CHEBI:12962 (1)
CHEBI:132477 (1)
CHEBI:132479 (1)
CHEBI:132948 (1)
CHEBI:132994 (1)
CHEBI:133005 (1)
CHEBI:133028 (1)
CHEBI:133032 (1)
CHEBI:133057 (1)
CHEBI:133066 (1)
CHEBI:133077 (1)
CHEBI:133092 (1)
CHEBI:133096 (1)
CHEBI:133115 (1)
CHEBI:133119 (1)
CHEBI:133139 (1)
CHEBI:133141 (1)
CHEBI:133144 (1)
CHEBI:133172 (1)
CHEBI:133176 (1)
CHEBI:133185 (1)
CHEBI:133186 (1)
CHEBI:133199 (1)
CHEBI:133435 (1)
CHEBI:133460 (1)
CHEBI:133469 (1)

Metabolite Name

(R)-3-hydroxybutyrylcarnitine (1)
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4)* (1)
1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)* (1)
1-(1-enyl-palmitoyl)-2-linoleoyl-GPC (P-16:0/18:2)* (1)
1-(1-enyl-palmitoyl)-2-linoleoyl-GPE (P-16:0/18:2)* (1)
1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1)* (1)
1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0)* (1)
1-(1-enyl-palmitoyl)-GPE (P-16:0)* (1)
1-(1-enyl-stearoyl)-GPE (P-18:0)* (1)
1-arachidonoyl-GPI (20:4)* (1)
1-lignoceroyl-GPC (24:0) (1)
1-linoleoyl-GPE (18:2)* (1)
1-linoleoyl-GPI (18:2)* (1)
1-methyl-4-imidazoleacetate (1)
1-methylguanidine (1)
1-methylhistidine (1)
1-methylnicotinamide (1)
1-myristoyl-2-palmitoyl-GPC (14:0/16:0) (1)
1-oleoyl-2-docosahexaenoyl-GPC (18:1/22:6)* (1)
1-oleoyl-2-linoleoyl-GPE (18:1/18:2)* (1)
1-oleoyl-GPI (18:1) (1)
1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4)* (1)
1-palmitoyl-2-arachidonoyl-GPI (16:0/20:4)* (1)
1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) (1)
1-palmitoyl-2-docosahexaenoyl-GPE (16:0/22:6)* (1)
1-palmitoyl-2-linoleoyl-GPE (16:0/18:2) (1)
1-palmitoyl-2-oleoyl-GPC (16:0/18:1) (1)
1-palmitoyl-2-oleoyl-GPI (16:0/18:1)* (1)
1-palmitoyl-2-palmitoleoyl-GPC (16:0/16:1)* (1)
1-palmitoyl-2-stearoyl-GPC (16:0/18:0) (1)

Study type

Transcription profiling by array (3)
Comparative genomic hybridization by array (1)
RNA-seq of coding RNA from single cells (1)

Release Date

2024 (25)
2023 (23)
2018 (18)
2022 (17)
2020 (16)
2025 (14)
2021 (13)
2016 (11)
2015 (10)
2019 (10)
2017 (9)
2014 (6)
2013 (5)
2012 (4)
2026 (2)
2011 (1)
2008 (1)

Lab affiliation

Human Immunological Diseases Section, Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, NIAID, NIH, Department of Health and Human Services, Unites States Government (1)
Mass Spectrometry Proteomics The Francis Crick Institute Midland Road London NW1 1AT UK (1)

Previous page
1 / 20
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 20
Next page

Sort by:

Relevance

Page size

Chemodivergent C(sp³)-H and C(sp²)-H Cyanomethylation Using Engineered Carbene Transferases.

Not available

S-EPMC9983643 | biostudies-literature

Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer.

Not available

S-EPMC3397696 | biostudies-literature

ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is a heterogeneous disease with distinct molecular subtypes described as classical/progenitor and basal-like/squamous PDAC. We hypothesized that integrative transcriptome and metabolome approaches can identify candidate genes whose inactivation contributes to ...

2024-04-02 | MTBLS9418 | MetaboLights

Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation.

Not available

S-EPMC8654800 | biostudies-literature

Metabolomics of the interaction between PPAR-alpha and age in the PPAR-alpha-null mouse (NMR assay)

Regulation between the fed and fasted state in mammals is partially controlled by peroxisome proliferator activated receptor-alpha (PPAR-alpha). Expression of the receptor is high in liver, heart and skeletal muscle, but decreases with age. A combined 1H NMR spectroscopy and GC-MS metabolomic approa...

2018-10-11 | MTBLS261 | MetaboLights

Single-cell transcriptional landscape of human embryonic limb development - Visium

We performed spatial transcriptomic experiments using the 10x Visium assay, generating high-quality transcriptomic profiles for samples from PCW5 to PCW8

ORGANISM(S): Homo sapiens

2022-04-15 | E-MTAB-10367 | biostudies-arrayexpress

Spotlight on afatinib and its potential in the treatment of squamous cell lung cancer: the evidence so far.

Not available

S-EPMC4888861 | biostudies-literature

Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin.

Not available

S-EPMC4767608 | biostudies-literature

Identification and regulation of circulating tumor-TCR-matched cytotoxic CD4+ lymphocytes by KLRG1 in bladder cancer.

Not available

S-EPMC12220972 | biostudies-literature

xCT inhibition sensitizes tumors to γ-radiation via glutathione reduction.